Programme
FRIDAY 1st JUNE 2018 |
||
14:00 – 14:45 |
Registration & Reception |
|
14:00 – 14:45 |
Group Welcome Lunch |
|
14:45 – 15:00 |
Opening Comments |
|
PERSPECTIVES OF AD PATHOGENESIS |
||
15:00 – 15:45 |
David Holtzman Washington University in St. Louis |
APOE: ROLE IN AMYLOID-β ACCUMULATION AND IN TAU-MEDIATED NEURODEGENERATION |
15:45 – 16:00 |
Zhengui Xia |
GENE-ENVIRONMENT INTERACTION BETWEEN LEAD AND APOLIPOPROTEIN E4 CAUSES COGNITIVE BEHAVIOR DEFICITS IN MICE |
16:00 – 16:30 |
Guojun Bu |
PATHOBIOLOGY AND THERAPEUTIC TARGETING OF APOE IN ALZHEIMER’S DISEASE |
16:30 – 17:00 |
Sangram Sisodia |
MODULATION OF AMYLOID DEPOSITION AND NEUROINFLAMMATION BY THE MICROBIOME |
17:00 – 17:30 |
Refreshments |
|
STEM CELLS IN AD |
||
17:30 – 18:00 |
Orly Lazarov |
THERAPEUTIC AND DIAGNOSTIC POTENTIAL OF CREB IN ALZHEIMER’S DISEASE |
18:00 – 18:30 |
Mathew Blurton-Jones |
USING iPSC-DERIVED MICROGLIA AND HUMANIZED MICE TO STUDY THE FUNCTIONAL GENOMICS OF ALZHEIMERS DISEASE |
18:30 – 19:00 |
Yadong Huang |
ALZHEIMERS DISEASE MODELING AND DRUG SCREENING USING HUMAN IPSCS |
19:00 – 19:30 |
Giulio Taglialatela |
NEURAL STEM CELLS PROMOTE SYNAPTIC RESILIENCE TO DAMAGING Ab AND TAU OLIGOMERS VIA EXOSOME DELIVERY OF SELECTED MIRNA CARGOES |
19:30 – 20:00 |
Riqiang Yan |
ENHANCING NEUROGENESIS TO REVERSE NEURONAL LOSS IN AD MOUSE MODELS |
20:00 |
Group Dinner |
SATURDAY 2nd JUNE 2018 |
||
07:00 – 08:30 |
Breakfast |
|
GENETICS AND EPIGENETICS OF AD |
||
08:30 – 09:00 |
Gerard Schellenberg |
GENETIC STUDIES OF ALZHEIMERS DISEASE; IDENTIFICATION OF THERAPEUTIC TARGETS |
09:00 – 09:30 |
Jeffery Vance |
IDENTIFYING A PROTECTIVE FACTOR FOR APOE4 |
09:30 – 10:00 |
Richard Mayeux |
GENETIC AND GENOMIC CONTRIBUTIONS TO ALZHEIMER’S DISEASE FROM THE CARIBBEAN ISLANDS |
10:00 – 10:30 |
Rita Cacace |
EXPLORING THE MISSING GENETICS OF EARLY ONSET ALZHEIMER’S DISEASE: INSIGHTS FROM GENOMIC STUDIES IN AUTOSOMAL DOMINANT FAMILIES |
10:30 |
Group Photo & Refreshments |
|
10:45 – 16:15 |
Free Time |
|
12:30 – 15:00 |
Snorkel Trip (Signups required in advance) |
|
MOLECULAR MECHANISM OF AD PATHOGENESIS |
||
16:15 – 16:45 |
Peter St George-Hyslop |
PHYSIOLOGICAL AND PATHOLOGICAL PHASE SEPARATION OF FUS IS REGULATED BY METHYLATION OF COOPERATIVE CROSS-DOMAIN CATION-PI INTERACTIONS AND INTERACTION WITH TNPO1 |
16:45 – 17:15 |
Domenico Praticò |
THE LEUKOTRIENES PATHWAY AS A VIABLE THERAPEUTIC TARGET FOR TAUOPATHIES |
17:15 – 17:45 |
Charles Glabe |
PLX3397, A CSF1R/C-KIT INHIBITOR, ABLATES MICROGLIA AND BLOCKS THE ACCUMULATION OF INTRANEURONAL AMYLOID AND NEURITIC PLAQUES IN 5XFAD MICE |
17:45 – 18:15 |
Refreshments |
|
18:15 – 18:30 |
Cara Croft |
rAAV-MEDIATED BRAIN SLICE CULTURE MODELS TO DEVELOP TAU-BASED THERAPEUTICS |
18:30 – 19:00 |
Sally Ishizaka |
IMMUNO-DEMENTIA: HUMAN GENETICS-GUIDED DRUG DISCOVERY IN ALZEIMERS DISEASE |
19:00 – 19:30 |
Taisuke Tomita |
NOVEL STRATEGIES FOR FACILITATION OF AMYLOID CLEARANCE IN THE BRAIN |
19:30 |
Group Dinner |
SUNDAY 3rd JUNE 2018 |
||
07:00 – 08:30 |
Breakfast |
|
NEURO-INFLAMMATION IN AD |
||
08:30 – 09:15 |
Li-Huei Tsai |
DECIPHERING THE IMMUNE RESPONSE OF MICROGLIA IN NEURODEGENERATION USING SINGLE-CELL RNA-SEQUENCING |
09:15 – 09:45 |
Guy Brown |
NEURODEGENERATION CAUSED BY MICROGLIAL PHAGOCYTOSIS OF NEURONS |
09:45 – 10:15 |
Elizabeth M. Bradshaw |
ARE CD33 SIALIC-ACID DEPENDENT BINDING PARTNERS THERAPEUTIC TARGETS FOR AD? |
10:15 – 10:45 |
Refreshments |
|
10:45 – 11:15 |
Damian Crowther |
TREM2 METABOLISM AT THE CELL SURFACE: OPTIONS FOR THERAPEUTIC MODULATION |
11:15 – 11:45 |
Jennifer Pocock |
TREM2 VARIANTS; RAMIFICATIONS FOR MICROGLIAL FUNCTION |
11:45 – 12:15 |
Philip L. De Jager |
POPULATION STRUCTURE OF HUMAN MICROGLIA: WHICH SUBSET OF MICROGLIA DO WE TARGET FOR TAU AND/OR AMYLOID PATHOLOGY? |
12:15 – 17:30 |
Lunch at Leisure & Free Time |
|
SECRETASES IN AD THERAPY |
||
17:30 – 18:00 |
Robert Vassar |
BACE1 AS A THERAPEUTIC TARGET FOR ALZHEIMER’S DISEASE |
18:00 – 18:15 |
Brati Das |
DELETION OF BACE1 IN ADULT AD MICE REVERSES AMYLOID DEPOSITION AND IMPROVES SYNAPTIC FUNCTION |
18:15 – 18:45 |
Giuseppina Tesco |
BACE1 UPS AND DOWNS: IMPLICATIONS FOR AD |
18:45 – 19:15 |
Yueming Li |
HYPOXIA AND GAMMA-SECRETASE |
19:45 |
*Gala Dinner* |
MONDAY 4th JUNE 2018 |
||
07:00 – 08:30 |
Breakfast |
|
NOVEL TARGETS IN AD THERAPY |
||
08:30 – 09:00 |
Huaxi Xu |
NOVEL ROLES FOR ALZHEIMER’S RISK GENE SORLA IN NEUROPROTECTION |
09:00 – 09:30 |
Nikolaos Robakis |
PS1-REGULATED NEUROPROTECTIVE NMDAR COMPLEXES ARE INACTIVATED BY FAD MUTANTS |
09:30 – 10:00 |
Gang Yu |
GAMMA-SECRETASE, GLIA/IMMUNE FUNCTION, AND ALZHEIMER’S DISEASE? |
10:00 – 10:30 |
Refreshments |
|
10:30 – 10:45 |
Ronald Davis |
SMALL MOLECULE PROBES TARGETING NEURONAL MITOCHONDRIAL DYNAMICS INCREASE ATP PRODUCTION, RESCUE OXIDATIVE STRESS AND AMYLOID BETA MEDIATED NEUROTOXICITY |
10:45 – 11:15 |
Xiongwei Zhu |
ABNORMAL MITOCHONDRIAL DYNAMICS AS A THERAPEUTIC TARGET OF ALZHEIMER DISEASE |
11:15 – 11:30 |
Closing Comments by Peter St. George-Hyslop and Riqiang Yan |